© Springer International Publishing Switzerland 2016David S. Cooper and Cosimo Durante (eds.)Thyroid Cancer10.1007/978-3-319-22401-5_21 21. A Patient with Postsurgical Recurrent Laryngeal Nerve Damage and Nerve Monitoring David L. Steward1 and Adam D. Goodale1 (1) Department of Otolaryngology – Head &…
-hydroxylated vitamin D analogues, most patients with hypoparathyroidism have been shifted to treatment with either alfacalcidol or calcitriol, as the plasma half-life of activated vitamin D metabolites is much shorter…
Risk from T4 therapy Response to therapy Excellent (mU/L) Indeterminate (mU/L) Biochemically incomplete (mU/L) Structurally incomplete (mU/L) Minimal 0.5–2.0a 0.1–0.5 <0.1 <0.1 Moderate 0.5–2.0a 0.5–2.0a 0.1–0.5 <0.1 High 0.5–2.0a 0.5–2.0a…
Features Sensitivity (%) Specificity (%) NPV (%) PPV (%) Accuracy (%) Prevalence (%) in normal LNs Suspicious for malignancy Punctate hyperechogenicity 5–69 93–100 33–60 88–100 56–72 0 Cystic aspect 10–34…
Fig. 13.1 Trend of serial basal Tg determination during the first 5 years after thyroidectomy. The graph line displays the Tg levels obtained with a highly sensitive immunometric assay (functional…
Fig. 14.1 Overall survival is significantly better in patients demonstrating a biochemical incomplete response to therapy than patients demonstrating a structural incomplete response to therapy (Kaplan–Meier analysis, p < 0.0001) (Adapted from…
Fig. 10.1 Follicular thyroid cancer demonstrating capsular invasion of tumor Literature Review Definition Follicular thyroid cancer (FTC) is a differentiated thyroid cancer, representing approximately 5.5 % of all thyroid malignancies…
© Springer International Publishing Switzerland 2016David S. Cooper and Cosimo Durante (eds.)Thyroid Cancer10.1007/978-3-319-22401-5_8 8. A Case of a Papillary Thyroid Cancer with Lymph Node Metastases Found on Prophylactic Central Neck Dissection (Subclinical Disease, Micrometastases) Ian D. Hay1 …
Category Cytology diagnostic category Malignancy risk (%) I Nondiagnostic or unsatisfactory 1–4 II Benign 0–3 III AUS/FLUS 5–15 IV FN/SFN or SHCN 15–30 V Suspicious for malignancy 60–75 VI Malignant…
© Springer International Publishing Switzerland 2016David S. Cooper and Cosimo Durante (eds.)Thyroid Cancer10.1007/978-3-319-22401-5_11 11. A Young Patient with Intrathyroidal Papillary Thyroid Cancer and Family History of Differentiated Thyroid Cancer Cosimo Durante1 , Fabiana Trulli2 and Sebastiano Filetti1 (1) Department…
